Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo.
- Resource Type
- Article
- Source
- Drug Design, Development & Therapy; Oct2020, Vol. 14, p4189-4203, 15p
- Subject
- Language
- ISSN
- 11778881